|
Dr. Silver is a board-certified internist and medical oncologist, a fellow of the American College of Physicians, and a member of the American Society of Clinical Oncology. He has twenty years of clinical oncology experience using chemo- and endocrine therapies, biologics, and therapeutic radiation and has experience in the post-transplant management of patients undergoing autologous and allogeneic transplants. Dr. Silver is a graduate of the University of Maryland School of Medicine and received training in internal medicine at the Johns Hopkins Hospital and in medical oncology at the medicine branch of the National Cancer Institute, where he conducted research into the immunophysiology of non-Hodgkin's lymphoma. Dr. Silver has participated in numerous clinical trials involving novel treatments for breast, colon, ovary, and lung cancers, lymphomas and Hodgkin's disease and in supportive care studies of hematopoietic growth factors. He has served as chairman of the department of medicine, cancer committee, and tumor boards and as principal site investigator for studies by the Eastern Cooperative Oncology Group (ECOG) and National Surgical Adjuvant Breast and Bowel Project (NSABP) at various hospitals at which he has practiced. Dr. Silver joined PRA International, a global CRO, in 2001 as a medical director and was promoted to vice-president, global product development services in 2005, where he provided oncology drug development consulting services to numerous biotechnology and pharmaceutical clients and managed clinical trials involving a variety of conventional and novel antineoplastic agents. | 